“The Standard of Care in Relapsed Refractory CD30+ Lymphoma”
Department of Hematology, Rigshospitalet, Copenhagen, Denmark
*Correspondence to email@example.com
Disclosure: Consultant/advisor to Genentech and Takeda/Millennium.
Support: The author would like to thank Dr Caroline Charles for medical writing assistance with this manuscript.
Received: 12.05.14 Accepted: 23.05.14
Citation: EMJ Hema. 2014;1:62-69.
Available in EMJ Hematology 2014 – http://viewer.zmags.com/publication/3d823163#/3d823163/63
Also available for download via our website – http://emjreviews.com/therapeutic-area/hematology/standard-care-relapsed-refractory-cd30-lymphoma/
Year of Production: